Medpassport is our flagship software platform for patient relationship management. It is accessible online via PC or mobile device.
Medpassport collects and analyzes patient data, and also facilitates communication between healthcare professionals and patients.Read more
Diabeo: innovative tool for diabetes management
Diabeo,an innovative telemedicine solution for diabetes management, is the result of a joint venture between CERITD (a leading French diabetes research institute), Voluntis and Sanofi.
Diabeo supports diabetes treatment. It has already proven its clinical efficacy among type 1 diabetes patients.Read more
10 years' experienceRead more
505 000 patients record managed
50 solutions available in 10 countries
20 therapeutic areas covered
ISO 9001 and ISO 13485 certifications
Patient relationship management
Voluntis is a medical software company. We develop web and mobile solutions for monitoring and supporting patients in order to help healthcare organizations.
Therapeutic software solutions
As a manufacturer of medical software devices, Voluntis provides healthcare professionals and patients with innovative solutions that signal the advent of connected treatment.
Voluntis, a company pioneering companion software, has been granted renewal of the ISO 9001: 2008 certification for the quality management system and ISO 13485: 2003 certification for the manufacture of software medical devices.Read more
Diabeo highlighted on October 15th at Objets de la Nouvelle France Industrielle by Mr Arnaud Montebourg, Ministre du Redressement ProductifOn October15, Diabeo, the companion software for diabetes patients, was presented in Paris by Dr. Geneviève d'Orsay, Chief Medical Officer at voluntis, during the conferences Objets de la Nouvelle France Industrielle (ONFI).Read more
- Voluntis wins the 2013 Up and Coming Company Award at the 12th Annual Business Awards Dinner of the French American Chamber of Commerce in Boston.Read more
Voluntis appoints Nicolas Cartier to the Supervisory Board as an Independent Director.Read more
- Voluntis release a new major version of the medpassport framework. Based on a modular architecture, medpassport 5.0 includes a new design, a mobile devices management module and an extended private messaging tool.Read more
Voluntis strengthens the leadership team and appoints Dr. Geneviève d'Orsay as a Chief Medical Officer.Read more
- Voluntis strengthens the leadership team and appoints Alexandre Capet as a Chief Strategy & Marketing Officer.Read more
Voluntis strengthens the leadership team and appoints Dominique Laubier as a Chief FinancialOfficer.Read more
- Voluntis is invited by the Care Continuum Alliance to speak at the International Symposium on Wellness & Chronic Care. Pierre Leurent, CEO and founder of Voluntis, will share his view regarding the development, the evaluation and the reimbursement of mobile and cloud-based diabetes management solutions.Read more